Status:
COMPLETED
Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Lead Sponsor:
Nobelpharma
Conditions:
Wison's Disease
Eligibility:
All Genders
1+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.
Eligibility Criteria
Inclusion
- Wilson's disease(adult,infant,pregnant woman)
Exclusion
- acute hepatitis
- malignant tumor
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00212368
Start Date
October 1 2004
End Date
December 1 2005
Last Update
September 10 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.